Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prediction of Desvenlafaxine Response in MDD Using fMRI
NCT02330679Phase 4Unknown
- Sponsor
- University of Calgary
- Start
- Dec 2014
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of desvenlafaxine in major depressive disorder (MDD), sponsored by University of Calgary. Status: unknown.
02
Drugs
desvenlafaxine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT02330679.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02330679.